Guides

Pipeline drugs

New drugs are being developed in existing and new drug classes.

Following reseach can help you plan when to change and when to wait. There may be studies you can join to use new drugs.

The i-Base website includes updates on new drugs and new research.
https://i-base.info/pipeline-2017

This includes the following compounds in each class. Not all these new drugs will work against drug resistance.

NRTIs: EFdA, GS-9131.

NNRTIs: doravirine, elsufavirine.

Integrase inhibitors: cabotegravir (similar to dolutegravir), and bictegravir.

Attachment inhibitors: fostemsavir, combinectin.

Fusion inhibitors: albuvirtide.

Maturation inhibitors: GSK3640254.

Monoclonal antibodies (mAbs): ibalizumab, UB-421, PRO-140.

Additional drugs might become available before this booklet is next updated.

www.PipelineReport.org

Last updated: 1 January 2018.